Detalles de la búsqueda
1.
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.
Pharmacogenet Genomics
; 33(6): 126-135, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306344
2.
Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa.
J Infect Dis
; 226(1): 147-156, 2022 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35091749
3.
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
Pharmacogenet Genomics
; 32(1): 24-30, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34369424
4.
Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens.
Clin Infect Dis
; 73(7): e2153-e2163, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32829410
5.
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine.
Pharmacogenet Genomics
; 31(1): 17-27, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32815870
6.
Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives.
Pharmacogenet Genomics
; 30(3): 45-53, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32106141
7.
Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation.
Pharmacogenet Genomics
; 28(1): 1-6, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29117017
8.
Drug metabolism and transport gene polymorphisms and efavirenz adverse effects in Brazilian HIV-positive individuals.
J Antimicrob Chemother
; 73(9): 2460-2467, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29868865
9.
Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.
Pharmacogenet Genomics
; 26(10): 473-80, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27509478
10.
Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia.
Gut
; 63(5): 800-7, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23935004
11.
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.
J Antimicrob Chemother
; 69(8): 2175-82, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24729586
12.
Hepatic Steatosis and Ectopic Fat Are Associated With Differences in Subcutaneous Adipose Tissue Gene Expression in People With HIV.
Hepatol Commun
; 5(7): 1224-1237, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34278171
13.
Adipose Tissue in Persons With HIV Is Enriched for CD4+ T Effector Memory and T Effector Memory RA+ Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance.
Front Immunol
; 10: 408, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941121
14.
Pleiotropic and sex-specific effects of cancer GWAS SNPs on melanoma risk in the population architecture using genomics and epidemiology (PAGE) study.
PLoS One
; 10(3): e0120491, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25789475
15.
Rare variant APOC3 R19X is associated with cardio-protective profiles in a diverse population-based survey as part of the Epidemiologic Architecture for Genes Linked to Environment Study.
Circ Cardiovasc Genet
; 7(6): 848-53, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25363704
16.
Replication of associations between GWAS SNPs and melanoma risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
J Invest Dermatol
; 134(7): 2049-2052, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24480881
Resultados
1 -
16
de 16
1
Próxima >
>>